Abstract
Conclusions: High-dose IMRT with intraprostatic fiducial markers is associated with a very low toxicity and with a significant lower rate of GI and GU complications compared to 3DCRT even considering the lower follow-up for the IMRT cohort. These data confirms that this technique is safe to deliver radiation dose above 80 Gy. Author Disclosure: A. Zapatero: None. F. Garcia-Vicente: None. C. Matin de Vidales: None. G. Rodriguez: None. O. Leaman: None. R. Bermudez: None. A. Cruz-Conde: None. O. Linan: None. L. Perez: None. J. Torres: None.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Paper Title
Journal
Date
